Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Merck keytruda patent expiry?Mounjaro tirzepatide patent expiration date us?Fda tirzepatide shortage end date 2024?Keytruda patent expiration us?Average cost of prolia injection?
See the DrugPatentWatch profile for Sirolimus
Sirolimus is sold under the brand name Rapamune. It is an mTOR inhibitor used to help prevent organ transplant rejection and, in some settings, treat certain lymphangioleiomyomatosis (LAM)–related conditions.
Rapamune is the best-known trade name for sirolimus. In some countries, availability and branding can vary by manufacturer and formulation, but “Rapamune” is the standard brand reference for sirolimus in common medical use.
Rapamune is manufactured by Pfizer.
Yes. Sirolimus has generic versions (not always marketed under the Rapamune name), but the branded trade name most clinicians and patients recognize is Rapamune.
Other Questions About Sirolimus :